SUNPHARMA's weekly performance was lackluster, with a return of -1.11% and a Sharpe Ratio of -0.29, indicating poor risk-adjusted returns. The stock's volatility was moderate at 20.28%, which is relatively in line with its peers. Compared to its peers, SUNPHARMA outperformed DRREDDY and DIVISLAB but underperformed HINDUNILVR. Overall, the stock was moderately risky this week.

[Volatility: 20.28%]